Meeting
2013 Gastrointestinal Cancers Symposium
Post-progression survival (PPS) and improvements in progression-free survival (PFS) in randomized controlled trials (RCTs) in advanced gastric cancer (AGC).
Authors
Kohei Shitara
National Cancer Center Hopsital East
Kohei Shitara , Marc Buyse , Everardo Saad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr93)
DOI
10.1200/jco.2013.31.4_suppl.93
Abstract #
93
Poster Bd #
B37
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.
First Author: Yoon-Koo Kang
Poster
2017 ASCO Quality Care Symposium
Uptake and effectiveness of FOLFIRINOX for advanced pancreas cancer: A population-based study.
First Author: Safiya Karim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of intensifying supportive care with improved survival in patients with gastric cancer with malignant ascites.
First Author: John D Karalis
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The effects of pre-existing psychiatric disorders on gastric cancer survival.
First Author: Josephine Soddano